HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered oligosaccharide structures reduce colitis induction in mice defective in β-1,4-galactosyltransferase.

AbstractBACKGROUND & AIMS:
Oligosaccharide modifications induce various functional changes in immune cells. The galactose-deficient fraction of fucosylated IgG oligosaccharides is increased, whereas that of β-1,4-galactosyltransferase I (B4GalTI) is reduced, in patients with Crohn's disease. We investigated the role of oligosaccharide modification in the pathophysiology of colitis using B4galt1-deficient mice.
METHODS:
Colitis severity was compared between B4galt1(+/-) and B4galt1(+/+) mice. B cells isolated from B4galt1(+/-) and B4galt1(+/+) mice were adoptively transferred to recombination activating gene 2(-/-) mice, in which colitis was induced by administration of CD4(+)CD62L(+) T cells. Cell-surface glycan profiles were determined by lectin microarray analysis. Cytokine production was determined in a coculture of various types of cells isolated from either B4galt1(+/-) or B4galt1(+/+) mice.
RESULTS:
Colitis induction by dextran sodium sulfate or trinitrobenzene sulfonic acid was significantly reduced in B4galt1(+/-) mice, which had galactose deficiency in IgG oligosaccharides (similar to patients with Crohn's disease) compared with B4galt1(+/+) mice. Amelioration of colitis was associated with increased production of interleukin-10 by macrophages in B4galt1(+/-) mice. Colitis induction in recombination activating gene 2(-/-) mice by administration of CD4(+)CD62L(+) T cells was reduced by cotransfer of B cells isolated from B4galt1(+/-), but not from B4galt1(+/+) mice. Lectin microarray analysis revealed increased expression of polylactosamines on B4galt1(+/-) B cells and macrophages, compared with B4galt1(+/+) cells. The production of interleukin-10 from macrophages was induced via their direct interaction with B4galt1(+/-) B cells.
CONCLUSIONS:
Altered oligosaccharide structures on immune cells modulate mucosal inflammation. Oligosaccharides in immune cells might be a therapeutic target for inflammatory bowel diseases.
AuthorsShinichiro Shinzaki, Hideki Iijima, Hironobu Fujii, Eri Kuroki, Norika Tatsunaka, Takahiro Inoue, Sachiko Nakajima, Satoshi Egawa, Tatsuya Kanto, Masahiko Tsujii, Eiichi Morii, Shunsaku Takeishi, Masahide Asano, Tetsuo Takehara, Norio Hayashi, Eiji Miyoshi
JournalGastroenterology (Gastroenterology) Vol. 142 Issue 5 Pg. 1172-82 (May 2012) ISSN: 1528-0012 [Electronic] United States
PMID22333949 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • CD11b Antigen
  • Galectins
  • Oligosaccharides
  • Interleukin-10
  • Galactosyltransferases
  • beta-1,4-galactosyltransferase I
Topics
  • Animals
  • CD11b Antigen (analysis)
  • Cell Communication
  • Colitis (immunology, prevention & control)
  • Galactosyltransferases (physiology)
  • Galectins (physiology)
  • Interleukin-10 (biosynthesis)
  • Macrophages (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Oligosaccharides (chemistry, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: